Preclinical CRO Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Preclinical CRO Market
The Preclinical CRO market size was valued at USD 6.84 billion in 2023, and the market is now projected to grow from USD 7.79 billion in 2024 to USD 19.41 billion by 2032, exhibiting a CAGR of 13.9% during the forecast period of 2024-2032.
In the phase of novel COVID-19 the market experienced in general critical development in the year 2020 due to the expanded number of preclinical considers driven by the expanded demand for immunizations and therapeutics. In the post-COVID-19 havoc by the year 2021 the preclinical CRO market growth witnessed a promising development essentially in the global market. This was due to the expanded entrance of CROs for conducting preclinical ponders. Advertise players experienced development in their income post-COVID-19 flare-up in 2021.
Higher preclinical considerations fetched is one of the reasons for expanded pharmaceutical R&D investing. Researches for the contract organizations play a vital part in helping producers spare time and cash by decreasing trial term. The rise in normal R&D costs may be due to changes within the sorts of pharmaceuticals being delivered or due to the number of drugs experiencing costly inquire about studies. R&D consumptions are higher in case the preclinical consider victory rate of biologics is lower compared to the conventional small atom pharmaceuticals.
The burden of life-threatening illnesses such as cancer, neurological conditions, and heart illnesses has been rising at ana exponential rate critically. The expanding predominance of these inveterate maladies has fueled the request for the improvement of successful novel therapeutics. Pharmaceutical and biotechnology companies have expanded their venture in R&D for investigational modern drug improvement.
Comprehensive Analysis of Preclinical CRO Market
The market structure on the basis of type is sectioned into safety services, drug metabolism and pharmacokinetics (DMPK), toxicity studies and bioanalysis. The safety services section took the lead of all the listed type. On the reference of application analysis, the market further is fragmented into infectious diseases, cardiology, neurology, oncology and metabolic disorders. The leading fragment of the above applications was the oncology part. On the analysis of end-user basis, the market for preclinical CRO was divided into academic and research institutes, pharmaceutical and biotechnological companies.
The North American territory accounted for a majority of stake in the preclinical CRO market share, with a net revenue generation of USD 3.42 billion in the forecasted period. The regional development is credited to expanded investing by pharmaceutical companies on Research & Development to progress their investigate considers, which has been fueling the showcase development.
Icon plc (Ireland), Novotech (Australia), Medpace (U.S.), Syneos Health (U.S.), EVOTECH (Germany) Laboratory Corporation of America Holdings (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eurofins Discovery (U.S.) and Charles River Laboratories (U.S.) are a few of the critical market players as they captured a significant worldwide market share in 2022. The solid development of these companies within the market is credited to their solid center on R&D to present unused arrangements and upgrade their offerings.
In the year end 2021 by December, the company by the name Thermo Fisher Scientific Inc. procured Pharmaceutical Item Improvement, LLC. This procurement upgraded the administrations given by the company.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2017-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2017-2021
Growth Rate CAGR of 13.9% from 2023-2030
Unit Value (USD billion)
Segmentation
By Type
Drug Metabolism and Pharmacokinetics (DMPK)
Bioanalysis
Toxicology Studies
Safety services
By Application
Oncology
Neurology
Cardiology
Infectious Diseases
Metabolic Disorders
Others
By End-user
Pharmaceutical & Biotechnological Companies
Academic & Research Institutes
Others
By Region
North America (By Type, By Application, By End-user, and By Country)
U.S.
Canada
Europe (By Type, By Application, By End-user, and By Country/Sub-region)
U.K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia Pacific (By Type, By Application, By End-user, and By Country/Sub-region)
Japan
China
Australia
India
Southeast Asia
Rest of Asia Pacific
Rest of the World (By Type, By Application, and By End-user)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Number of Preclinical Trials Conducted – by Key Countries/ Regions, 2022
- 4.2. R&D Investment – by Key Players
- 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.4. Impact of COVID-19 on the Market
- 5. Global Preclinical CRO Market Analysis, Insights and Forecast, 2019-2030
- 5.1. Market Analysis, Insights and Forecast – By Type
- 5.1.1. Drug Metabolim and Pharmacokinetics (DMPK)
- 5.1.2. Bioanalysis
- 5.1.3. Toxicology Studies
- 5.1.4. Safety Services
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Oncology
- 5.2.2. Neurology
- 5.2.3. Cardiology
- 5.2.4. Infectious Disease
- 5.2.5. Metabolic Disorder
- 5.2.6. Others
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Pharmaceutical & Biotechnological Companies
- 5.3.2. Academic & Government Research Institutes
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia pacific
- 5.4.4. Rest of the World
- 6. North America Preclinical CRO Market Analysis, Insights and Forecast, 2019-2030
- 6.1. Market Analysis, Insights and Forecast – By Type
- 6.1.1. Drug Metabolim and Pharmacokinetics (DMPK)
- 6.1.2. Bioanalysis
- 6.1.3. Toxicology Studies
- 6.1.4. Safety Services
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Oncology
- 6.2.2. Neurology
- 6.2.3. Cardiology
- 6.2.4. Infectious Disease
- 6.2.5. Metabolic Disorder
- 6.2.6. Others
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Pharmaceutical & Biotechnological Companies
- 6.3.2. Academic & Government Research Institutes
- 6.3.3. Others
- 6.4. Market Analysis – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Preclinical CRO Market Analysis, Insights and Forecast, 2019-2030
- 7.1. Market Analysis, Insights and Forecast – By Type
- 7.1.1. Drug Metabolim and Pharmacokinetics (DMPK)
- 7.1.2. Bioanalysis
- 7.1.3. Toxicology Studies
- 7.1.4. Safety Services
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Oncology
- 7.2.2. Neurology
- 7.2.3. Cardiology
- 7.2.4. Infectious Disease
- 7.2.5. Metabolic Disorder
- 7.2.6. Others
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Pharmaceutical & Biotechnological Companies
- 7.3.2. Academic & Government Research Institutes
- 7.3.3. Others
- 7.4. Market Analysis – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia pacific Preclinical CRO Market Analysis, Insights and Forecast, 2019-2030
- 8.1. Market Analysis, Insights and Forecast – By Type
- 8.1.1. Drug Metabolim and Pharmacokinetics (DMPK)
- 8.1.2. Bioanalysis
- 8.1.3. Toxicology Studies
- 8.1.4. Safety Services
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Oncology
- 8.2.2. Neurology
- 8.2.3. Cardiology
- 8.2.4. Infectious Disease
- 8.2.5. Metabolic Disorder
- 8.2.6. Others
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Pharmaceutical & Biotechnological Companies
- 8.3.2. Academic & Government Research Institutes
- 8.3.3. Others
- 8.4. Market Analysis – By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Rest of the World Preclinical CRO Market Analysis, Insights and Forecast, 2019-2030
- 9.1. Market Analysis, Insights and Forecast – By Type
- 9.1.1. Drug Metabolim and Pharmacokinetics (DMPK)
- 9.1.2. Bioanalysis
- 9.1.3. Toxicology Studies
- 9.1.4. Safety Services
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Oncology
- 9.2.2. Neurology
- 9.2.3. Cardiology
- 9.2.4. Infectious Disease
- 9.2.5. Metabolic Disorder
- 9.2.6. Others
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Pharmaceutical & Biotechnological Companies
- 9.3.2. Academic & Government Research Institutes
- 9.3.3. Others
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis (2022)
- 10.2. Company Profiles
- 10.2.1. Novotech
- 10.2.1.1. Overview
- 10.2.1.2. Services
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Strategies
- 10.2.1.6. Financials (Based on Availability)
- 10.2.2. Thermo Fisher Scientific Inc.
- 10.2.2.1. Overview
- 10.2.2.2. Services
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Strategies
- 10.2.2.6. Financials (Based on Availability)
- 10.2.3. Medpace
- 10.2.3.1. Overview
- 10.2.3.2. Services
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Strategies
- 10.2.3.6. Financials (Based on Availability)
- 10.2.4. Icon plc
- 10.2.4.1. Overview
- 10.2.4.2. Services
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Strategies
- 10.2.4.6. Financials (Based on Availability)
- 10.2.5. Syneos Health
- 10.2.5.1. Overview
- 10.2.5.2. Services
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Strategies
- 10.2.5.6. Financials (Based on Availability)
- 10.2.6. Eurofins Discovery
- 10.2.6.1. Overview
- 10.2.6.2. Services
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Strategies
- 10.2.6.6. Financials (Based on Availability)
- 10.2.7. EVOTEC
- 10.2.7.1. Overview
- 10.2.7.2. Services
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Strategies
- 10.2.7.6. Financials (Based on Availability)
- 10.2.8. Charles River Laboratories
- 10.2.8.1. Overview
- 10.2.8.2. Services
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Strategies
- 10.2.8.6. Financials (Based on Availability)
- 10.2.9. WuXi AppTec
- 10.2.9.1. Overview
- 10.2.9.2. Services
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Strategies
- 10.2.9.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook